We recognize that the reduced levels of estrogen in the ovariectomized mice used for our in vivo experiment may have influenced androgen signaling which have been showed to promote breast tumor growth and metastasis through different mechanisms including the activation of the HER2-downstream PI3K/PTEN and ERK pathways (39, 40). Here, ERBB2 is linked to breast neoplasm.